DNA polymerase ε catalytic (pol ε cat) inhibitors are a class of chemical compounds specifically designed to target and inhibit the catalytic activity of the DNA polymerase ε enzyme, a critical enzyme involved in the leading-strand DNA synthesis during replication. DNA pol ε plays a key role in maintaining high fidelity during DNA replication, contributing to the accurate duplication of the genome. The catalytic domain of DNA pol ε contains the active site responsible for nucleotide addition during the synthesis of the new DNA strand. Inhibitors of DNA pol ε cat work by binding to this catalytic region, thereby blocking the incorporation of nucleotides into the growing DNA strand. These inhibitors can act through different mechanisms, including competitive inhibition, where they directly compete with natural nucleotide substrates, or non-competitive mechanisms, where binding at a site other than the active site induces structural changes that reduce catalytic efficiency. The goal in designing DNA pol ε cat inhibitors is to achieve high specificity for the catalytic subunit of the enzyme, ensuring minimal off-target effects on other related polymerases involved in DNA synthesis.
The development of DNA pol ε cat inhibitors involves a deep understanding of the enzyme's structure and the molecular interactions necessary for its catalytic function. Structural biology techniques, such as X-ray crystallography and cryo-electron microscopy (cryo-EM), are used to elucidate the three-dimensional configuration of DNA pol ε, providing detailed insights into its active site architecture and the arrangement of important catalytic residues. This structural information allows researchers to identify key binding pockets and regions suitable for inhibitor binding. Computational approaches, such as molecular docking and molecular dynamics simulations, are then employed to model the interactions between potential inhibitors and the catalytic site of DNA pol ε, helping to optimize their binding affinity and selectivity. Structure-activity relationship (SAR) analysis is used to modify the chemical structure of inhibitors to enhance their ability to bind to the catalytic domain, focusing on improving properties such as solubility, stability, and selectivity. DNA pol ε cat inhibitors may include small organic molecules that fit precisely into the enzyme's active site, designed to form specific interactions such as hydrogen bonds with catalytic residues or hydrophobic contacts within the binding pocket. The successful development of these inhibitors requires an iterative approach of chemical synthesis, structural analysis, and computational modeling, aiming to achieve effective inhibition of DNA pol ε catalytic activity and better understand its role in DNA replication.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide may directly downregulate gene transcription by inhibiting RNA polymerase II, potentially leading to a decrease in DNA pol ε cat mRNA synthesis and subsequent protein expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could cause hypomethylation of the DNA pol ε cat gene promoter, resulting in the transcriptional repression of this gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin can suppress cellular proliferation and protein translation via mTOR inhibition, which may result in a decreased translation rate of DNA pol ε cat. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
As an antimetabolite, Fluorouracil may lead to the misincorporation of its metabolites into RNA, causing a reduction in the transcription efficiency of DNA pol ε cat. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A could cause chromatin remodeling that leads to transcriptional silencing of the DNA pol ε cat gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA at the transcription initiation complex, inhibiting RNA polymerase movement and causing a decrease in DNA pol ε cat mRNA transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and preferentially interacts with GC-rich sequences, which could repress the promoter activity of the DNA pol ε cat gene, leading to reduced expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II phosphorylation, stalling transcription elongation and potentially leading to a decrease in DNA pol ε cat mRNA levels. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This toxin binds with high affinity to RNA polymerase II, causing strong inhibition of mRNA elongation and consequently decreasing the synthesis of the DNA pol ε cat mRNA. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases which are critical for cell cycle progression, potentially causing cell cycle arrest and subsequent downregulation of DNA pol ε cat expression. | ||||||